Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 264

Sort by

Sort Order Select

Journal Articles

β2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia Effect

Hemn Mohammadpour, PhD DVM, Joseph L. Sarow, BS, George L. Chen, MD, Cameron R. MacDonald, BS, Umesh Sharma, MD, Megan M. Herr, PhD, Theresa E. Hahn, PhD, Elizabeth A. Repasky, PhD, Philip L. McCarthy, MD

Blood (2019) 134 (Supplement_1): 1915.

https://doi.org/10.1182/blood-2019-123139

Published: 2019

Journal Articles

Development of T-Cell Therapy Targeting Hematopoietic Minor Histocompatibility Antigen HA-1

Artem Pilunov, MSc, Dmitrii Romaniuk, MSc, Savely Sheetikov, MSc, Alexandra Khmelevskaya, Anton Shmelev, PhD, Nadia Bykova, Alina Shomuradova, Dmitry Olegovych Kiryukhin, Dmitry Dianov, Grigory Aleksandrovich Efimov, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5749.

https://doi.org/10.1182/blood-2019-130552

Published: 2019

Journal Articles

Towards Predicting Graft Vs Host Disease from Predicted Tissue Specific Minor Histocompatibility Antigens

Max Jameson-Lee, PhD, Amir Ahmed Toor, MBBS, Kang Le, PhD, Vishal Koparde, PhD, Brian Di Pace, PhD, Erin Donahue, PhD, Cathy Roberts, PhD, Gregory Buck, PhD, Michael Neale, PhD

Blood (2018) 132 (Supplement 1): 3395.

https://doi.org/10.1182/blood-2018-99-119783

Published: 2018

Journal Articles

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Lucia Zanotti, PhD, Gabriele Bucci, PhD, Francesco Santaniello, Cristina Toffalori, Donatella Biancolini, PhD, Ettore Zapparoli, Laura Zito, Matteo Giovanni Carrabba, MD, Friedrich Stoelzel, Martin Bornhäuser, Massimo Bernardi, MD, Jacopo Peccatori, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, Giovanni Tonon, MD PhD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2018) 132 (Supplement 1): 819.

https://doi.org/10.1182/blood-2018-99-111769

Published: 2018

Journal Articles

Donor T Cell Independent Mechanism Is Critical for Mediating Steroid Refractory Gvhd in Murine Models

Tomomi Toubai, MDPhD, Corrine Rossi, Isao Tawara, MD PhD, Chen Liu, MD PhD, Cynthia Zajac, Katherine Oravecz-Wilson, BS, MS, Dan Peltier, MD, Yaping Sun, MD PhD MS, Hideaki Fujiwara, MD, Mary Mansour Riwes, DO, Israel Henig, MD, Stephanie Kim, BS, Masahiro Suto, Kenichi Ishizawa, MD PhD, Pavan Reddy, MD

Blood (2018) 132 (Supplement 1): 4529.

https://doi.org/10.1182/blood-2018-99-114634

Published: 2018

Journal Articles

Recurrent Genetic HLA Loss in Acute Myeloid Leukemia Relapsed after Matched Unrelated Allogeneic Hematopoietic Cell Transplant

Blood (2018) 132 (Supplement 1): 817.

https://doi.org/10.1182/blood-2018-99-113911

Published: 2018

Journal Articles

Pembrolizumab for the Treatment of Disease Relapse Following Allogeneic Hematopoietic Cell Transplantation

Justin Kline, MD, Hongtao Liu, MD PhD, Tallarico Michael, MD, Andrew S Artz, MD, James Godfrey, MD, Emily K Curran, MD, Wendy Stock, MD, Sonali M. Smith, MD, Michael R. Bishop, MD

Blood (2018) 132 (Supplement 1): 3415.

https://doi.org/10.1182/blood-2018-99-115108

Published: 2018

Journal Articles

Off-the-shelf TCR for graft-versus-leukemia without GVHD

Frederick L. Locke, Claudio Anasetti

Blood (2018) 131 (1): 5–7.

https://doi.org/10.1182/blood-2017-11-812990

Published: 2018

Journal Articles

Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning

Meng Zhou, Jinling Liu, PhD, Warren D Shlomchik, MD

Blood (2017) 130 (Supplement 1): 4436.

https://doi.org/10.1182/blood.V130.Suppl_1.4436.4436

Published: 2017

Journal Articles

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Jefferson L. Lansford, BS, Udara Dharmasiri, PhD, Shengjie Chai, BS, Sally A. Hunsucker, PhD, Dante S. Bortone, PhD, James E. Keating, BS, Ian M. Schlup, Gary L. Glish, PhD, Edward J. Collins, PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2017) 130 (Supplement 1): 207.

https://doi.org/10.1182/blood.V130.Suppl_1.207.207

Published: 2017

Journal Articles

Mechanisms of GVL-Resistance: T Cell Exhaustion and a Failure of Antigen Cross-Presentation

Meng Zhou, Sarah Rosenberger, Kai Zhao, PhD, Hong Zheng, MDPhD, Warren D Shlomchik, MD

Blood (2017) 130 (Supplement 1): 4461.

https://doi.org/10.1182/blood.V130.Suppl_1.4461.4461

Published: 2017

Journal Articles

Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following Allogeneic Hematopoietic Cell Transplantation

Charlotte McIlwaine Story, BS, MD, Jefferson L. Lansford, BS, Dominic T. Moore, MPH, MS, Chang Xu, Benjamin G. Vincent, MD, Paul M. Armistead, MD PhD, Marcie L. Riches, MDMS

Blood (2017) 130 (Supplement 1): 1987.

https://doi.org/10.1182/blood.V130.Suppl_1.1987.1987

Published: 2017

Journal Articles

Vaccination with a DNA and MVA ‘Prime-Boost’ Regimen Induces Strong CD8 + T-Cell Responses Against the Immunodominant Minor Histocompatibility Antigen, HA-1: Results of a First-in-Man Phase I Clinical Trial

Charlotte F Inman, BVSc, PhD, Suzy A Eldershaw, BSc. (Hons.), PhD, Hayden Pearce, BSc. (Hons.), PhD, Ben E Abbotts, BSc. (Hons.), MSc., Mirjana Sirovica, BSc(Hons), MSc, Paul Ferguson, MD PhD MRCP, Donna L Walsh, Dip(HE), BSc., Jane Nunnick, BSC. (Hons.), MSc., Shamyla Siddique, BSc.(Hons.), MPhil, Paul Moss, MBBS, PhD FRCP, Ram K Malladi, FRCPath

Blood (2017) 130 (Supplement 1): 1908.

https://doi.org/10.1182/blood.V130.Suppl_1.1908.1908

Published: 2017

Journal Articles

Highly Variable Frequencies of Donor Antigen-Specific Naive Cells May Dictate the Immunogenicity of Minor Histocompatibility Antigens after Hematopoietic Stem Cell Transplantation

Anna Kuchmiy, Savely Sheetikov, Dmitrii Romaniuk, Anna Postovskaya, Sergey Filkin, Nadia Bykova, Grigory Efimov, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3171.

https://doi.org/10.1182/blood.V130.Suppl_1.3171.3171

Published: 2017

Journal Articles

Major vs minor histocompatibility antigens

Denis Claude Roy, Claude Perreault

Blood (2017) 129 (6): 664–666.

https://doi.org/10.1182/blood-2016-12-754515

Published: 2017

Journal Articles

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease

Paul J. Martin, David M. Levine, Barry E. Storer, Edus H. Warren, Xiuwen Zheng, Sarah C. Nelson, Anajane G. Smith, Bo K. Mortensen, John A. Hansen

Blood (2017) 129 (6): 791–798.

https://doi.org/10.1182/blood-2016-09-737700

Published: 2017

Includes: Supplemental data

Journal Articles

Whole Transcriptome Sequencing (RNAseq) As a Comprehensive, Cost-Efficient Diagnostic Tool for Acute Myeloid Leukemia

Marieke Griffioen, PhD, Wibowo Arindrarto, MSc, Daniel Borràs, MSc, Saskia A.M.E. van Diessen, BSc, Edith D. van der Meijden, M. Willy Honders, Mariam Alloul, PhD, Inge Jedema, PhD, Wilma G.M. Kroes, PhD, Peter J.M. Valk, PhD, Bart Janssen, PhD, Cornelis A.M. van Bergen, PhD, Szymon M. Kiełbasa, PhD, Jeroen F.J. Laros, PhD, Peter A.C. 't Hoen, PhD, Hendrik Veelken, MD PhD

Blood (2016) 128 (22): 1701.

https://doi.org/10.1182/blood.V128.22.1701.1701

Published: 2016

Journal Articles

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

Blood (2016) 128 (22): 3350.

https://doi.org/10.1182/blood.V128.22.3350.3350

Published: 2016

Journal Articles

Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Jefferson L. Lansford, Shengjie Chai, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2016) 128 (22): 3352.

https://doi.org/10.1182/blood.V128.22.3352.3352

Published: 2016

Journal Articles

Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT

Blood (2016) 128 (22): 3472.

https://doi.org/10.1182/blood.V128.22.3472.3472

Published: 2016

NARROW

β2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia Effect

Development of T-Cell Therapy Targeting Hematopoietic Minor Histocompatibility Antigen HA-1

Towards Predicting Graft Vs Host Disease from Predicted Tissue Specific Minor Histocompatibility Antigens

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Donor T Cell Independent Mechanism Is Critical for Mediating Steroid Refractory Gvhd in Murine Models

Recurrent Genetic HLA Loss in Acute Myeloid Leukemia Relapsed after Matched Unrelated Allogeneic Hematopoietic Cell Transplant

Pembrolizumab for the Treatment of Disease Relapse Following Allogeneic Hematopoietic Cell Transplantation

Off-the-shelf TCR for graft-versus-leukemia without GVHD

Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Mechanisms of GVL-Resistance: T Cell Exhaustion and a Failure of Antigen Cross-Presentation

Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following Allogeneic Hematopoietic Cell Transplantation

Vaccination with a DNA and MVA ‘Prime-Boost’ Regimen Induces Strong CD8 + T-Cell Responses Against the Immunodominant Minor Histocompatibility Antigen, HA-1: Results of a First-in-Man Phase I Clinical Trial

Highly Variable Frequencies of Donor Antigen-Specific Naive Cells May Dictate the Immunogenicity of Minor Histocompatibility Antigens after Hematopoietic Stem Cell Transplantation

Major vs minor histocompatibility antigens

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease

Whole Transcriptome Sequencing (RNAseq) As a Comprehensive, Cost-Efficient Diagnostic Tool for Acute Myeloid Leukemia

Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model

Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only